Ten years with biosimilar rhGH in clinical practice in Sweden - experience from the prospective PATRO children and adult studies.

Lundberg E, Kriström B, Zouater H, Deleskog A, Höybye C

Open source

DOI
10.1186/s12902-020-0535-4
Published
2020 Apr 29
Container
BMC endocrine disorders
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12902-020-0535-4,
  title = {Ten years with biosimilar rhGH in clinical practice in Sweden - experience from the prospective PATRO children and adult studies.},
  author = {Lundberg E and Kriström B and Zouater H and Deleskog A and Höybye C},
  year = {2020},
  journal = {BMC endocrine disorders},
  doi = {10.1186/s12902-020-0535-4},
  url = {https://doi.org/10.1186/s12902-020-0535-4}
}

RIS

TY  - JOUR
TI  - Ten years with biosimilar rhGH in clinical practice in Sweden - experience from the prospective PATRO children and adult studies.
AU  - Lundberg E
AU  - Kriström B
AU  - Zouater H
AU  - Deleskog A
AU  - Höybye C
PY  - 2020
JO  - BMC endocrine disorders
DO  - 10.1186/s12902-020-0535-4
UR  - https://doi.org/10.1186/s12902-020-0535-4
ER  - 

APA

E, L., B, K., H, Z., A, D., & C, H. (2020). Ten years with biosimilar rhGH in clinical practice in Sweden - experience from the prospective PATRO children and adult studies.. BMC endocrine disorders. https://doi.org/10.1186/s12902-020-0535-4

Source records